Search

everythinglearnresearchcommunity

for

Search:↓

Lack of Ctip2 in skin cells delays wound healing and disrupts hair follicle stem cell markers in mice.

Fingerprints form uniquely before birth due to specific genetic pathways and local signals.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Overexpression of sPLA2-IIA in mouse skin reduces hair stem cells and increases cell differentiation through JNK/c-Jun pathway activation.

Cetuximab can cause unusual hair growth and hair loss.

PRP is effective for treating hair loss, especially with other treatments.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Prunus mira kernels contain components that can promote hair growth in mice.

The hexosamine pathway helps protect skin cells from stress and may improve skin and hair health.

Type I interferons play a key role in the development of various skin diseases.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Activating TRPV3 stops human hair growth.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Stem cells compete for space using cell adhesion, and mutations can affect their competitive success, with implications for tissue health and disease.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

The document concludes that a better understanding of cell changes during wound healing could improve treatments for chronic wounds and other conditions.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.